Cargando…

The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer

SIMPLE SUMMARY: Breast cancer is one of the most prevalent cancers worldwide, surpassing lung cancer as the leading cause of overall cancer incidence. Available possible treatments nowadays include chemotherapy, hormonal therapy, and HER2-targeted therapy. Chemotherapy is notorious for its severe ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amer, Hoda T., Stein, Ulrike, El Tayebi, Hend M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658645/ https://www.ncbi.nlm.nih.gov/pubmed/36358879 http://dx.doi.org/10.3390/cancers14215460

Ejemplares similares

A cutting-edge immunomodulatory interlinkage between HOTAIR and MALAT1 in tumor-associated macrophages in breast cancer: A personalized immunotherapeutic approach
por: Amer, Hoda T., et al.
Publicado: (2022)

Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration
por: Yamaguchi, Ryuji, et al.
Publicado: (2018)

Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer
por: Ho, Teresa, et al.
Publicado: (2021)

Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers
por: Schuler, Linda A., et al.
Publicado: (2021)

Editorial: Tumor microenvironment (TME) and tumor immune microenvironment (TIME): New perspectives for prognosis and therapy
por: Ramos, Rodrigo Nalio, et al.
Publicado: (2022)

The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME)
por: DiPalma, Michelle P., et al.
Publicado: (2023)

OTME-3. Dissection of the role of stromal microenvironment and tumor-TME crosstalk in pediatric brain cancer
por: Federico, Aniello, et al.
Publicado: (2021)

Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study
por: Ali, Sehar, et al.
Publicado: (2021)

Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
por: Elgohary, Sawsan, et al.
Publicado: (2021)

The clinical role of the TME in solid cancer
por: Giraldo, Nicolas A., et al.
Publicado: (2018)

Transanal TME – really needed?
por: Dapri, Giovanni
Publicado: (2017)

GNAI2 Is a Risk Factor for Gastric Cancer: Study of Tumor Microenvironment (TME) and Establishment of Immune Risk Score (IRS)
por: Yu, Han, et al.
Publicado: (2022)

Transanal TME: new standard or fad?
por: Hasegawa, Suguru, et al.
Publicado: (2019)

The Potential Role of the T2 Ribonucleases in TME-Based Cancer Therapy
por: Campomenosi, Paola, et al.
Publicado: (2023)

TME quality in rectal cancer surgery
por: Herzog, T, et al.
Publicado: (2010)

The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression
por: Lee, Sook Shien, et al.
Publicado: (2019)

Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges
por: Kamal, Monica A., et al.
Publicado: (2022)

Retracted: GNAI2 Is a Risk Factor for Gastric Cancer: Study of Tumor Microenvironment (TME) and Establishment of Immune Risk Score (IRS)
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

TaTME approach as a rescue during a laparoscopic TME for high rectal cancer. A case report
por: Carannante, F., et al.
Publicado: (2021)

Patient Derived Organoids (PDOs), Extracellular Matrix (ECM), Tumor Microenvironment (TME) and Drug Screening: State of the Art and Clinical Implications of Ovarian Cancer Organoids in the Era of Precision Medicine
por: Spagnol, Giulia, et al.
Publicado: (2023)

Crosstalk among m(6)A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
por: Zhang, Fusheng, et al.
Publicado: (2022)

From the EAA conference on the TME
por: Romero, Diana
Publicado: (2020)

taTME: boom or bust?
por: Kang, Liang, et al.
Publicado: (2020)

Managing the TME to improve the efficacy of cancer therapy
por: Bilotta, Maria Teresa, et al.
Publicado: (2022)

Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice
por: Brand, Matthias, et al.
Publicado: (2020)

TME-Responsive Multistage Nanoplatform for siRNA Delivery and Effective Cancer Therapy
por: Cao, Shuwen, et al.
Publicado: (2021)

Long-term oncologic outcomes of transanal TME compared with transabdominal TME for rectal cancer: a systematic review and meta-analysis
por: Moon, Jae Young, et al.
Publicado: (2021)

COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer
por: Deijen, Charlotte L., et al.
Publicado: (2015)

Intratumoral Monocyte Transfer to Examine Monocyte Differentiation in the Tumor Microenvironment
por: Devalaraja, Samir, et al.
Publicado: (2020)

Prognostic utility of TME-associated genes in pancreatic cancer
por: Nie, Yuanhua, et al.
Publicado: (2023)

The tumor microenvironment and inflammatory breast cancer
por: Huang, Aji, et al.
Publicado: (2017)

Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers
por: Sulaiman, Raed, et al.
Publicado: (2023)

XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients
por: Salama, Esraa A., et al.
Publicado: (2020)

Response to: the nearly complete TME quality conundrum
por: Pędziwiatr, M., et al.
Publicado: (2018)

Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer
por: Wang, Na, et al.
Publicado: (2021)

Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
por: He, Guangpeng, et al.
Publicado: (2022)

Robotic Transanal Total Mesorectal Excision (RTaTME): State of the Art
por: Rondelli, Fabio, et al.
Publicado: (2021)

Transanal total mesorectal excision for low rectal cancer: a case-matched study comparing TaTME versus standard laparoscopic TME
por: Rubinkiewicz, Mateusz, et al.
Publicado: (2018)

TME7/366: Borderless Teleradiology with CHILI
por: Engelmann, U, et al.
Publicado: (1999)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
por: Ghallab, Alaa M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j1tusg2sqfg4pkml5kl9mk00at